Table 2 Multivariable regression: factors associated with PrEP use in the recent 4 months among transgender women participating in the TLC study (n = 94)

1.65 (0.65–4.22)

0.292

1.59 (0.66–3.79)

0.299

3.13 (1.07–9.17)

0.038

2.91 (1.03–8.20)

0.043

2.95 (1.09–7.99)

0.034

2.73 (0.96–7.78)

0.060

1.48 (0.41–5.36)

0.552

1.05 (0.29–3.77)

0.946

1.61 (0.51–5.04)

0.415

1.03 (0.31–3.41)

0.956

2.86 (1.14–7.14)

0.025

2.80 (1.05–7.50)

0.040

2.64 (0.90–7.73)

0.078

2.93 (0.97–8.91)

0.057

5.00 (2.15–11.6)

< 0.001

3.97 (1.47–10.8)

0.007

3.67 (1.40–9.60)

0.008

3.80 (0.94–15.4)

0.061

1.01 (0.85–1.20)

0.893

0.96 (0.78–1.17)

0.672

1.80 (0.66–4.88)

0.251

1.38 (0.50–3.78)

0.532

0.41 (0.06–2.89)

0.370

0.22 (0.03–1.48)

0.120

1.50 (0.98–2.29)

0.060

1.92 (1.04–3.54)

0.037

0.81 (0.56–1.18)

0.281

0.74 (0.49–1.12)

0.151

0.76 (0.57–1.01)

0.055

0.71 (0.51-1.00)

0.052

0.82 (0.56–1.21)

0.320

0.81 (0.50–1.30)

0.378

0.98 (0.69–1.39)

0.911

0.96 (0.73–1.27)

0.787

0.76 (0.49–1.18)

0.216

0.63 (0.36–1.09)

0.100

2.42 (0.97-6.00)

0.058

2.70 (1.09–6.65)

0.031

1.57 (0.60–4.07)

0.358

1.35 (0.54–3.36)

0.521

3.11 (1.13–8.52)

0.028

2.40 (0.78–7.37)

0.125

2.42 (0.97-6.00)

0.058

2.05 (0.83–5.11)

0.121